...
首页> 外文期刊>The Journal of Infectious Diseases >Early evolution of hepatitis C virus (HCV) quasispecies after liver transplant for HCV-related disease.
【24h】

Early evolution of hepatitis C virus (HCV) quasispecies after liver transplant for HCV-related disease.

机译:肝移植后丙型肝炎病毒(HCV)准种的早期进化,用于HCV相关疾病。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: End-stage liver disease as a result of chronic hepatitis C virus (HCV) infection is the main indication for liver transplant (LT), but allografts are systematically infected with HCV soon after transplant. Viral quasispecies are poorly described during the early posttransplant period. METHODS: For 17 patients who received an LT for HCV disease, plasma viral quasispecies evolution was determined by sequence analysis of hypervariable region 1 of the E2 envelope gene before transplant (BT), after 7 days (D7), and after 1 month (M1). T helper (Th)1/Th2 cytokine levels were determined concomitantly. RESULTS: HCV quasispecies showed a significant decrease in amino acid diversity at D7 and M1, compared with BT (P<.05). A correlation was observed between low plasma tumor necrosis factor-alpha levels at D7 and decreased quasispecies amino acid complexity at the same date. Nucleic acid diversity was lower for genotype 1 than for genotype 3 infection (P<.05). The complexity and diversity of amino acids were lower in patients with hepatocellular carcinoma (HCC) BT than in those without HCC (P<.05). Conserved amino acid residues within quasispecies were shared by the whole cohort before and after LT. CONCLUSION: Viral structural and/or host immunological features could favor the emergence of fitter HCV strains after LT.
机译:背景:慢性丙型肝炎病毒(HCV)感染导致的终末期肝病是肝移植(LT)的主要适应症,但同种异体移植在移植后不久就被系统性感染。在移植后的早期,对病毒准种的描述很少。方法:对于接受HCV疾病LT的17例患者,通过在移植前(BT),7天(D7)和1个月(M1)后对E2包膜基因高变区1的序列分析确定血浆病毒准种的进化)。同时测定T辅助细胞(Th)1 / Th2的细胞因子水平。结果:与BT相比,准HCV准种在D7和M1的氨基酸多样性显着降低(P <.05)。观察到在D7血浆肿瘤坏死因子-α水平低与同一日期降低的准种氨基酸复杂性之间存在相关性。基因型1的核酸多样性低于基因型3的感染(P <.05)。肝细胞癌(HCC)BT患者的氨基酸复杂性和多样性要低于无肝细胞癌的患者(P <.05)。在LT之前和之后,整个队列共享准物种内的保守氨基酸残基。结论:病毒结构和/或宿主的免疫学特征可能有助于LT后出现更合适的HCV病毒株。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号